HomeCompanies › HRMY

Harmony Biosciences

Most recent annual filing: 2026-02-24

Catalyst timeline

12 trackedQuarter catalyst calendar →
  1. BP-205 Ph1 start3Q 2026BP-205 Ph1 start, 3Q 2026, routine
  2. BP-205 interim4Q 2026BP-205 interim, 4Q 2026, notable
  3. WAKIX litigation rulingOct 22, 2026WAKIX litigation ruling, Oct 22, 2026, material
  4. WAKIX / MSN License AgreementNov 2026WAKIX / MSN License Agreement, Nov 2026, notable
  5. EPX-100 ARGUS Ph3 topline1H 2027EPX-100 ARGUS Ph3 topline, 1H 2027, material
  6. Pitolisant HD ONSTRIDE 1 topline2027Pitolisant HD ONSTRIDE 1 topline, 2027, material
  7. Pitolisant GR PDUFA dateApr 1, 2027Pitolisant GR PDUFA date, Apr 1, 2027, material
  8. Pitolisant TEMPO Ph3 toplineMid-2027Pitolisant TEMPO Ph3 topline, Mid-2027, material
  9. BP-205 Ph2 startMid-2027BP-205 Ph2 start, Mid-2027, routine
  10. EPX-100 PDUFA date2028EPX-100 PDUFA date, 2028, material
  11. Pitolisant HD PDUFA date2028Pitolisant HD PDUFA date, 2028, material
  12. Pitolisant TEMPO PDUFA date2028Pitolisant TEMPO PDUFA date, 2028, material

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (17 active programs)

Technology platforms

CiRC cell replacement therapy platform · CiRC Biosciences

Discovery-stage cell replacement therapy platform developed in collaboration with CiRC Biosciences, targeting refractory epilepsies and treatment-resistant narcolepsy. Two discovery-stage candidates under research collaboration with option to license.

Discontinued (2)

Biotech Distilled coverage (1)

Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.